Cilo Cybin Pharmaceutical may list on the JSE within months, while it is also planning to start clinical trials of cannabis-derived drugs before the end of 2023, in partnership with its new Malaysian shareholder.
Cilo Cybin Pharmaceutical may list on the JSE within months, while it is also planning to start clinical trials of cannabis-derived drugs before the end of 2023, in partnership with its new Malaysian shareholder.
Find public sector tender opportunities in South Africa here.